tiprankstipranks
Panacea Life Sciences Holdings Inc (PLSH)
OTHER OTC:PLSH
US Market

Panacea Life Sciences Holdings Inc (PLSH) Income Statement

Compare
12 Followers

Panacea Life Sciences Holdings Inc Income Statement

Last quarter (Q3 2024), Panacea Life Sciences Holdings Inc's total revenue was $948.97K, an increase of 172.81% from the same quarter last year. In Q3, Panacea Life Sciences Holdings Inc's net income was $-1.13M. See Panacea Life Sciences Holdings Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.38M$ 1.63M$ 2.06M$ 9.02M$ 345.68K
Gross Profit
$ -4.09M$ 396.47K$ 540.58K$ 2.00M$ -1.70M
Operating Expenses
$ 2.37M$ 5.79M$ 6.08M$ 7.26M$ 8.97M
Depreciation and Amortization
$ 1.71M$ 1.73M$ 1.74M$ 1.69M$ 892.30K
EBITDA
$ -4.75M$ -5.36M$ -1.94M$ -2.03M$ -8.65M
Operating Income
$ -5.55M$ -5.40M$ -5.54M$ -5.26M$ -10.67M
Other Income/Expenses
$ -2.47M$ -3.49M$ 1.15M$ 26.01K$ 653.94K
Pretax Income
$ -8.02M$ -9.14M$ -4.78M$ -5.23M$ -10.02M
Net Income
$ -8.02M$ -11.10M$ -6.12M$ -6.99M$ -9.48M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.48$ -0.75$ -0.34$ -0.41$ -7.83
Diluted EPS
$ -0.48$ -0.75$ -0.34$ -0.41$ -7.83
Weighted Average Shares Outstanding
16.63M 14.86M 17.82M 16.92M 1.21M
Weighted Average Shares Outstanding (Diluted)
16.63M 14.86M 17.82M 16.92M 1.21M
Currency in USD

Panacea Life Sciences Holdings Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis